Dudediligence.

Exelixis, Inc

EXELNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$2.38Blast 12 months
Net income
$833.4Mlast 12 months
Operating cash flow
$924.7Mlast 12 months
Cash and equivalents
$281.4Mat the last balance sheet
Shares outstanding
248.9M shareson issue
Every year and quarter →